These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hormonal therapy for metastatic male breast cancer. Kantarjian H; Yap HY; Hortobagyi G; Buzdar A; Blumenschein G Arch Intern Med; 1983 Feb; 143(2):237-40. PubMed ID: 6824391 [TBL] [Abstract][Full Text] [Related]
23. [Medical considerations on the treatment of metastasizing mammary carcinoma (author's transl)]. Lissner J; Kessler M MMW Munch Med Wochenschr; 1975 Jul; 117(29-30):1233-8. PubMed ID: 51474 [TBL] [Abstract][Full Text] [Related]
24. Antiestrogen-induced remissions in stage IV breast cancer. Manni A; Trujillo J; Marshall JS; Pearson OH Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225 [TBL] [Abstract][Full Text] [Related]
25. Endocrine manipulation in the treatment of breast cancer. Segaloff A Clin Obstet Gynecol; 1975 Jun; 18(2):227-37. PubMed ID: 166781 [No Abstract] [Full Text] [Related]
26. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women. Klaassen DJ; Rapp EF; Hirte WE Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780 [TBL] [Abstract][Full Text] [Related]
27. [Experimental and clinical aspects of hormone therapy in breast cancer (author's transl)]. Maass H; Jonat W Arch Geschwulstforsch; 1981; 51(7):623-9. PubMed ID: 7337544 [TBL] [Abstract][Full Text] [Related]
28. [Progress in the treatment of metastasizing mammary carcinoma]. Nagel GA; Senn HJ; Renner KH Schweiz Rundsch Med Prax; 1971 Nov; 60(44):1460-8. PubMed ID: 4946677 [No Abstract] [Full Text] [Related]
29. Hormonal management of advanced breast cancer. Stoll BA Br Med J; 1969 May; 2(5652):293-7. PubMed ID: 5780457 [No Abstract] [Full Text] [Related]
30. [Hormone-therapy of carcinoma of the breast]. Villani C; Mazzon I Minerva Ginecol; 1981 Jan; 33(1):3-26. PubMed ID: 7017505 [No Abstract] [Full Text] [Related]
31. Hypophysectomy in the treatment of disseminated carcinoma of the breast and prostate gland. Tindall GT; Ambrose SS; Christy JH; Patton JM South Med J; 1976 May; 69(5):579-83. PubMed ID: 1273614 [TBL] [Abstract][Full Text] [Related]
32. Hormone therapy for cancer. II. Breast and prostate. Drug Ther Bull; 1970 Jul; 8(16):61-3. PubMed ID: 5453278 [No Abstract] [Full Text] [Related]
33. Antiestrogen treatment of breast cancer: an overview. Pearson OH; Manni A; Arafah BM Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524 [TBL] [Abstract][Full Text] [Related]
34. [Cancer risk under hormone therapy]. Lauritzen C Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334 [TBL] [Abstract][Full Text] [Related]
35. Endocrine therapy of breast and prostate cancer. Manni A Endocrinol Metab Clin North Am; 1989 Jun; 18(2):569-92. PubMed ID: 2663486 [TBL] [Abstract][Full Text] [Related]
37. [The choice of hormone treatment in breast carcinoma]. Schermuly W Radiologe; 1966 Jan; 6(1):12-22. PubMed ID: 4165533 [No Abstract] [Full Text] [Related]
38. Management of malignant disease metastatic to bone by hormonal alterations. Mellette SJ Clin Orthop Relat Res; 1970; 73():73-88. PubMed ID: 5479779 [No Abstract] [Full Text] [Related]
39. [Therapy of gynceologic diseases with ovarian hormones]. Friedrich F Wien Med Wochenschr; 1973 Jan; 123(1):11-4. PubMed ID: 4683448 [No Abstract] [Full Text] [Related]